10x Genomics (TXG) total liabilities

Total liabilities · fiscal 2025
$245.04M

10x Genomics (TXG) had total liabilities of $245.04M at the end of fiscal 2025 (December 31, 2025). That is 17.5% higher than the $208.50M of fiscal 2024. Figures as of 19 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$245.04M
Change on fiscal 2024
+17.5%
Growth, 5 years
+5.2% a year
Highest on record
$245.04Mfiscal 2025
Lowest on record
$101.05Mfiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

10x Genomics total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 5.2% a year. Across the 8 fiscal years on record (2018–2025), the highest was $245.04M in fiscal 2025 and the lowest $101.05M in fiscal 2018.

History · 8 fiscal years

Total liabilities by fiscal year

10x Genomics total liabilities, year by year

10x Genomics (TXG) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$245.04M 17.5% up
2024$208.50M 7.0% down
2023$224.10M 0.4% up
2022$223.24M 10.9% up
2021$201.26M 5.8% up
2020$190.27M 2.4% up
2019$185.84M 83.9% up
2018$101.05M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of 10x Genomics and comparable companies
CompanyTotal liabilitiesFiscal year
Twist Bioscience TWST$233.79M2026
Protagonist Therapeutics PTGX$53.48M2025
Krystal Biotech KRYS$114.23M2025
10x Genomics TXG$245.04M2025
HealthEquity HQY$1.27B2026
Corcept Therapeutics CORT$188.85M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TXG

10x Genomics, figure by figure

10x Genomics (TXG) overview: price, valuation and scorecardAll health care companies by market value

10x Genomics total liabilities: questions and answers

How large are 10x Genomics's total liabilities?

10x Genomics (TXG) had total liabilities of $245.04M at the end of fiscal 2025 (December 31, 2025). That is 17.5% higher than the $208.50M of fiscal 2024.

What is the growth rate of 10x Genomics's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 5.2% a year.

What are the highest and lowest total liabilities figures on record for 10x Genomics?

Across the 8 fiscal years on record (2018–2025), the highest was $245.04M in fiscal 2025 and the lowest $101.05M in fiscal 2018.

How is 10x Genomics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For 10x Genomics it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “10x Genomics (TXG) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/TXG/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.